Clinical Trial Outcome Prediction on ClinicalTrials.gov (Phase 1, 2, 3)
0.88ROC-AUC (Phase 2)Aliper, et al. (2023)
Evaluation results
| Method | Links | ||||
|---|---|---|---|---|---|
| Aliper, et al. (2023)Use of drug characteristic information=Yes2025.11 | 0.88 | — | — | 0.88 | |
| Lo, et al. (2017)Use of drug characteristic information=Yes2025.11 | 0.78 | — | 0.81 | 0.8 | |
| Gao, et al. (2024)Use of drug characteristic information=Yes2025.11 | 0.74 | 0.77 | 0.75 | 0.75 | |
| Feijoo, et al. (2020)Use of drug characteristic information=Yes2025.11 | 0.74 | — | 0.67 | 0.71 | |
| BioBERT-based modelUse of drug characteristic information=None (ClinicalTrials.gov only)2025.11 | 0.67 | 0.74 | 0.71 | 0.71 | |
| Fu, et al. (2020)Use of drug characteristic information=Yes2025.11 | 0.65 | 0.58 | 0.72 | 0.65 | |
| Zheng, et al. (2024)Use of drug characteristic information=Yes2025.11 | 0.65 | 0.65 | 0.74 | 0.68 |